Richard brings venture capital and finance experience from Northstar Ventures and Red Rover Interactive. He previously held investment roles at Accelerated Digital Ventures and Entrust.
Alex is an investment manager at Northstar Ventures. His prior experience includes equity sales at UBS and European sales leadership roles at Compugen and Strategic Diagnostics.
Rick brings investment and finance experience from roles at Northstar Ventures, Accelerated Digital Ventures, and Red Rover Interactive.
Stephen Price
Investment Director
Stephen brings early-stage investment experience across climate technology and deep tech. He serves as an investment director at Northstar Ventures and holds board observer and director roles at several portfolio companies.
Khadija brings deep tech investment experience from roles at Northern Gritstone and Northstar Ventures UK. She also served as a trustee at The Angelou Centre and a venture fellow at the Newton Venture Program.
Naomi is an investment manager at Northstar Ventures UK and a fellow at the Newton Venture Program, following earlier actuarial and consulting roles at St. James's Place Wealth Management.
Rebecca brings venture capital and operating experience from roles at Northstar, 7percent Ventures, and Oxford Seed Fund. She also serves as chief executive officer of Mason Capital Investments and co-founder of Unity Angels.
The investment round was led by Northstar Ventures with participation from Creative UK and angel investors.
"We are very pleased to complete our investment in Moralbox, which is the third investment from our Venture Sunderland Fund. The Fund supports innovative and scalable businesses with ambitious teams in Sunderland at all stages of their development. Moralbox is developing impressive AI powered training management software and is already working with well-established customers in key industries. We look forward to working with Gordon, John, Steve and the entire Moralbox team to accelerate the company’s growth."
The investment comprises £935k from Northstar Ventures, £150k from Creative UK, and funding from angel investors.
"We are excited to provide further support for MySalesCoach which has grown significantly since our initial investment in 2022 and is now well placed to scale further. Utilising our investor network to introduce Creative UK and new angel investors has provided additional capital to further accelerate the next stage of the business’ growth. MySalesCoach’s use of AI shows how businesses in the North East are adopting the latest technologies to deliver inventive solutions that make a real difference to their customers. We look forward to working with MySalesCoach in the next stage of their development and to seeing the business continue to flourish."
Northstar Ventures led the funding round, with participation from 24 Haymarket.
"It’s no surprise that OnHand is thriving, thanks to their exceptional leadership team. Our investment will support technical improvements to enhance the platform’s gamification and expand user options even further. It will also help the company achieve their ambition of breaking into the enterprise market. We are thrilled to support such an exciting, innovative company, as we recognise the value of corporate volunteering."
The funding round was backed by Northstar Ventures, early-stage investors and a grant from Innovate UK.
"We are very pleased to be providing further investment into Wordnerds, including a commitment from the new Northstar EIS Growth Fund. The team at Wordnerds has developed a sophisticated, market leading AI-enabled product which provides rapid and incisive analysis to consumer facing businesses. They have an impressive list of customers and have grown significantly since our initial investment. This round of funding will help them to grow their commercial and product development teams, which will enable Wordnerds to scale at pace. We’re excited to work with the team on the next stage of their development."
The funding round was backed by existing investors Mercia Ventures, NorthStar Ventures and North East Finance.
"Newcells has a great product and a strong team, and has the potential to become a leader in its field. The past year has been tough for the pharmaceutical industry as economic uncertainty has affected investment, resulting in fewer drugs under development. Newcells has navigated the changing markets effectively, while also improving efficiency and strengthening its commercial team. It is now well positioned for growth as activity levels recover and more companies make the decision to move away from animal testing."
.png)
